D-1045-2016 Class III Terminated

Recalled by Sandoz, Inc — Princeton, NJ

FDA drug recall D-1045-2016 was initiated by Sandoz, Inc on May 2, 2016 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing. The recall status is terminated (terminated Aug 17, 2017). Affected quantity: 78,606 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 29, 2016
Initiation Date
May 2, 2016
Termination Date
Aug 17, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
78,606 bottles

Product description

Dicloxacillin Sodium Capsules, USP 250mg, Rx Only, 100 Capsule Bottle, Manufactured in Austria by Sandoz Gmbh, Distributed by Sandoz Inc., Princeton, NJ 08540, Product of Spain, NDC 0781-2248-01

Reason for recall

Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.

Distribution pattern

Nationwide

Code information

Lot #s: EN3846, Exp 08/2016; FA4809, Exp 2/2017, FW3654 , Exp11/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1045-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1045-2016. Report a data issue: hello@regdatalab.com.